Skip to main content

LYRA

Lyra Therapeutics, Inc.

Company with tickers: LYRA

CIK
1327273
CUSIP
55234L204
Shares Outstanding
1,774,882
13F Activity (30d)
3 filings 2 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 1
Total Value: $51,103
Total Shares: 104,059

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 1 13F filers · Δ vs Dec 31, 2025
Top Holder
100.0%
Jun 2025 → Mar 2026 · range 51.1% – 100.0%
+27.8 pts
Top 5
100.0%
Jun 2025 → Mar 2026 · range 93.1% – 100.0%
+3.5 pts
Top 10
100.0%
Jun 2025 → Mar 2026 · range 98.6% – 100.0%
+0.4 pts
HHI
10,000
Jun 2025 → Mar 2026 · range 3,416 – 10,000
Highly concentrated +4,624

Quarterly Activity

vs Dec 31, 2025
New
0
Increased
0
Decreased
1
Sold Out
22
Unchanged
0
Holder count: -22
Institutional value: -93.2%
Shares held: -57.1%

Top Buyers

vs Dec 31, 2025
No qualifying movers this quarter.

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
No new positions this quarter.

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 1 of 1
Export CSV
Holder Value (USD) % of 13F Shares Open